News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
123 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (38)
2 (32)
3 (280)
4 (181)
5 (158)
6 (130)
7 (79)
8 (4)
9 (2)
10 (123)
11 (123)
12 (127)
13 (118)
14 (92)
15 (6)
16 (7)
17 (673)
18 (189)
19 (55)
20 (175)
21 (86)
22 (10)
23 (4)
24 (156)
25 (176)
26 (141)
27 (192)
28 (105)
30 (6)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
30
Press Releases
Cancer Immunotherapy Market Size to Hit USD 296.01 Billion by 2033
June 10, 2024
·
18 min read
Drug Development
Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024
Gannex Pharma Co., Ltd. announced a poster presentation at the European Association for the Study of the Liver Congress 2024, held June 5-8, 2024 in Milan, Italy.
June 10, 2024
·
8 min read
Drug Development
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE
Ascentage Pharma announced that the Center for Drug Evaluation of China’s National Medical Product Administration has approved a global registrational Phase III study of the company’s novel drug candidate olverembatinib, in patients with succinate dehydrogenase -deficient gastrointestinal stromal tumor who had failed prior systemic treatment.
June 10, 2024
·
8 min read
Previous
13 of 13
